The Riverside Company, a New York-based global private equity firm, has divested its interest in Global Orthopaedic Technologies (GOT), Australia’s maker of orthopaedic implants, to Corin Orthopaedic Holdings Limited (Corin), a UK-based firm, according to an announcement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com